ARCHIVES

Clanton Resigns From NCI.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

Duke, M.D. Anderson Receive Bristol-Myers Unrestricted Grants

May 5, 1989

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014